✦ LIBER ✦

Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations

✍ Scribed by Tyronne I Goonewardene; Marcia R Hall; Gordon JS Rustin

Book ID: 117784454
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 245 KB
Volume: 8
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(07)70273-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CA 125 in the follow-up of patients with

CA 125 in the follow-up of patients with ovarian cancer

✍ Koelbl, H.; Schieder, K.; Neunteufel, W.; Bieglmayer, C. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Whole-body PET with FDG is useful for fo

Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA-125 levels within the normal range

✍ Tetsuji Kurokawa; Yoshio Yoshida; Kazumi Kawahara; Tatsuro Tsuchida; Yasuhisa Fu 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 615 KB

8057 How relevant is the CA-125 monitori

8057 How relevant is the CA-125 monitoring for patients with ovarian cancer in the follow-up? – Results from a multicenter survey in 1060 patients with ovarian cancer

✍ Oskay-Özcelik, G.; Bois, A. du; Fasching, P.A.; Mahner, S.; Liebrich, C.; Glab, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

The value of serum CA125 for the develop

The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study

✍ Elizabeth Varughese, Srinivas Kondalsamy-Chennakesavan, Andreas Obermair 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 127 KB

Doxepin rinse for management of mucositi

Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy

✍ Joel B. Epstein; Joshua D. Epstein; Matthew S. Epstein; Hal Oien; Edmond L. True 📂 Article 📅 2008 🏛 Special Care Dentistry Association 🌐 English ⚖ 82 KB